Literature DB >> 3067810

In vitro activity of natural and synthetic naphthoquinones against erythrocytic stages of Plasmodium falciparum.

L H Carvalho1, E M Rocha, D S Raslan, A B Oliveira, A U Krettli.   

Abstract

In an attempt to identify new antimalarial compounds we studied the blood schizonticide effect of chemically defined natural products which were isolated from plants (Bignoniaceae) or synthesized. Different concentrations of these drugs (up to 20 microM) were incubated in vitro with blood forms of Plasmodium falciparum for 72 h. A total of 12 drugs of the naphthoquinones group were tested. Eight of them were isolated from plants (NP) and 4 synthesized (S). Three of the drugs (2 NP and one S) were very active and completely inhibited parasite growth at the higher concentrations used (20 microM); 5 drugs were partially active (3S and 2NP) and 3 (NP) were totally inactive. Lapachol was among the drugs tested. Although it has been considered a potential antimalarial agent, it exhibited very low activity (20% inhibition of schizogony). The antimalarial activity of our naphthoquinones against drug-resistant strains was superior to that of chloroquine and quinine which were used as controls. Two of the P. falciparum strains used for the tests were strongly chloroquine resistant. If these naphthoquinones prove to be active in vivo and are of low toxicity, they will be promising candidates for treatment of human malaria particularly since they are easily synthesized.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3067810

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  8 in total

1.  In vitro antiplasmodial activity and cytotoxicity of crude extracts and compounds from the stem bark of Kigelia africana (Lam.) Benth (Bignoniaceae).

Authors:  Denis Zofou; Archile Bernabe Ouambo Kengne; Mathieu Tene; Moses N Ngemenya; Pierre Tane; Vincent P K Titanji
Journal:  Parasitol Res       Date:  2011-04-13       Impact factor: 2.289

Review 2.  Antimalarial drugs currently in development.

Authors:  W E Gutteridge
Journal:  J R Soc Med       Date:  1989       Impact factor: 5.344

Review 3.  Natural products as starting points for future anti-malarial therapies: going back to our roots?

Authors:  Timothy N C Wells
Journal:  Malar J       Date:  2011-03-15       Impact factor: 2.979

4.  Synthesis, SAR, and Docking Studies Disclose 2-Arylfuran-1,4-naphthoquinones as In Vitro Antiplasmodial Hits.

Authors:  Tatiane Freitas Borgati; Maria Fernanda Alves do Nascimento; Juma Fortunato Bernardino; Lunamaura Claudia Oliveira Martins; Alex Gutterres Taranto; Alaíde Braga de Oliveira
Journal:  J Trop Med       Date:  2017-10-31

5.  Antioxidant Properties of Lapachol and Its Derivatives and Their Ability to Chelate Iron (II) Cation: DFT and QTAIM Studies.

Authors:  Djafarou Ngouh Pajoudoro; Daniel Lissouck; Baruch Ateba Amana; Joseph Zobo Mfomo; A E B Abdallah; Alfred Aristide Flavien Toze; Désiré Bikele Mama
Journal:  Bioinorg Chem Appl       Date:  2020-03-31       Impact factor: 7.778

6.  Characterization and trypanocidal activity of a β-lapachone-containing drug carrier.

Authors:  Juliana M C Barbosa; Caroline D Nicoletti; Patrícia B da Silva; Tatiana G Melo; Débora O Futuro; Vitor F Ferreira; Kelly Salomão
Journal:  PLoS One       Date:  2021-03-04       Impact factor: 3.752

7.  Blood shizonticidal activities of phenazines and naphthoquinoidal compounds against Plasmodium falciparum in vitro and in mice malaria studies.

Authors:  Nicolli Bellotti de Souza; Isabel M de Andrade; Paula F Carneiro; Guilherme A M Jardim; Isadora M M de Melo; Eufrânio N da Silva Júnior; Antoniana Ursine Krettli
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-08-05       Impact factor: 2.743

8.  Effects of a novel β-lapachone derivative on Trypanosoma cruzi: Parasite death involving apoptosis, autophagy and necrosis.

Authors:  Danielle Oliveira Dos Anjos; Eliomara Sousa Sobral Alves; Vinicius Tomaz Gonçalves; Sheila Suarez Fontes; Mateus Lima Nogueira; Ana Márcia Suarez-Fontes; João Batista Neves da Costa; Fabricio Rios-Santos; Marcos André Vannier-Santos
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2016-10-12       Impact factor: 4.284

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.